Code: Select all
01-Jan-20 | SP | % PFO | XIRR | 01-Jan-21 | SP | % PFO | XIRR | SP 20+/-
AZN | £76.07 | 3.4% | 29.2% | AZN | £73.24 | 3.4% | 19.3% | -3.72%
BP | £4.72 | 4.4% | 11.4% | BP | £2.55 | 4.0% | 3.2% | -45.93%
BATS | £32.32 | 4.9% | -19.6% | BATS | £27.08 | 4.2% | -14.1% | -16.20%
BLND | £6.39 | 3.8% | 9.5% | BLND | £4.89 | 4.6% | 3.0% | -23.45%
CCH | £25.65 | 3.9% | 9.4% | CCH | £23.77 | 5.6% | 5.3% | -7.33%
DGE | £32.01 | 7.2% | 12.6% | DGE | £28.78 | 6.8% | 10.5% | -10.08%
GSK | £17.79 | 4.6% | 5.6% | GSK | £13.42 | 4.2% | -0.6% | -24.56%
HSBA | £5.92 | 3.6% | 8.6% | HSBA | £3.79 | 3.3% | 29.4% | -35.97%
IMB | £18.69 | 2.8% | -17.3% | IMB | £15.36 | 2.4% | -16.5% | -17.82%
INCH | £7.06 | 6.4% | 12.6% | INCH | £6.44 | 3.4% | 12.2% | -8.78%
IHG | £52.08 | 3.7% | 9.7% | IHG | £46.90 | 5.3% | 7.5% | -9.95%
RB | £61.29 | 4.3% | -2.4% | RB | £65.42 | 4.7% | 1.5% | 6.74%
REL | £19.06 | 6.5% | 20.2% | REL | £17.93 | 6.3% | 18.6% | -5.90%
RIO | £45.03 | 3.7% | 29.9% | RIO | £54.70 | 4.7% | 63.9% | 21.47%
RR | £6.83 | 2.1% | 4.1% | RR | £1.11 | 2.6% | 3.0% | -83.75%
RDSB | £22.40 | 5.9% | 24.7% | RDSB | £12.59 | 3.9% | 15.4% | -43.78%
SN | £18.33 | 5.8% | 16.5% | SN | £15.10 | 5.0% | 7.3% | -17.60%
TATE | £7.60 | 1.8% | 19.7% | TATE | £6.74 | 3.2% | 4.9% | -11.34%
ULVR | £43.51 | 6.5% | 11.9% | ULVR | £43.92 | 5.2% | 11.5% | 0.95%
VOD | £1.47 | 6.6% | -8.2% | VOD | £1.21 | 5.7% | -9.5% | -17.55%
| | | | | | | |
SOLD | | | | BOUGHT | | | |
G4S | £2.18 | 3.3% | 10.5% | AV | £3.252 | 2.5% | 41.0% |
STAN | £7.124 | 4.3% | 10.8% | ITRK | £56.48 | 3.1% | -6.1% |
| | | | PZC | £2.30 | 2.1% | 34.4% |
| | | | JDW | £11.16 | 3.5% | 39.0% |
Full ISA allowance used as Additional Capital and all Dividend Income reinvested
DIVIDENDS
2020 - £9880.43, 2019 - £15,248.99, 2018 - £11,495.92, 2017 - £9586.05, 2016 - £7317.31, 2015 - £6821.33, 2014 - £6693.64
A synopsis of where by stock my dividend payouts came from (% of Total Income & Stock code):-
Code: Select all
13.71% | VOD | 3.97% | TATE
10.82% | BATS | 3.91% | ULVR
9.33% | BP | 3.36% | AZN
8.48% | RIO | 3.34% | CCH
7.05% | GSK | 3.24% | SN
6.90% | RDSB | 1.66% | BLND
6.30% | IMB | 1.56% | AV
5.44% | DGE | 0.94% | PZC
5.33% | REL | 0.47% | RR
4.18% | RB
YIELD - 3.10% based upon total cash payouts received relative to capital value at year end.
VALUE DECREASE - -12.12% Including Added Cash contributions, -13.65% Including Dividends received & Added Cash, -4.08% Total LOSS in Net Worth.
COMMENTARY
2020 was, short of armed conflict, about as catastrophic a year as one could imagine enduring. Stock performance, pretty irrelevant compared to human survival, is shown here: -
Code: Select all
RIO | 21.47% | BATS | -16.20%
RB | 6.74% | VOD | -17.55%
ULVR | 0.95% | SN | -17.60%
AZN | -3.72% | IMB | -17.82%
REL | -5.90% | BLND | -23.45%
CCH | -7.33% | GSK | -24.56%
INCH | -8.78% | HSBA | -35.97%
IHG | -9.95% | RDSB | -43.78%
DGE | -10.08% | BP | -45.93%
TATE | -11.34% | RR | -83.75%
Disposals during the year
G4S - I was concerned about the level of debt at the business albeit I was holding with a decent margin of safety. The pandemic then broke and I sold out completely 16 Apr 20, crystallising a loss, at 87p. Typically a long term predator arrives on the scene and makes a bid for the business. As I type G4S is 253p. A big mistake on my part, who in reality could have known though?!
StanChart - I was holding SC at a loss, pandemic broke and I sold out again 16 Apr 20 at 397p. No regrets here.
Acquisitions & Significant Activity during the year
Aviva - purchased 16 Apr 20 at 238p currently showing a gain of circa 38% and an XIRR of circa 41%.
Intertek - purchased 13 Nov 20 at 6097p currently held at a loss but a business with a decent sustainable ROCE. Time will tell.
PZ Cussons - purchased 16 Apr 20 at 175p currently showing a gain of circa 33% and an XIRR of circa 35%.
JD Wetherspoon - purchased 16 Apr 20 at 840p and again 12 Oct 20 at 955p currently gain 25%, XIRR 39%.
HSBC - I sold completely 16 Apr 20 at 404p then repurchased 12 Oct 20 at 312p. Lets hope dividends resume soon!
Rolls Royce - If G4S was the negative of 2020 then RR was the positive. I bet big on the RI, buying 05 Oct 20 at 115p and then disposing well (having bagged the Nil Paids) 12 Oct 20 at 229p. RR is therefore on my books with a margin of safety, albeit clearly a business with Problems.
Stock Tip for 2021
I'm going to completely overlook my tips for 2020, events overtook all else! I think for 2021 GSK at 1342p is far too cheap, BUY!
I lost two colleagues during the year and cycling around Central London did on some days see more Ambulances than Cars. As I type vast swathes of high-end shopping arcades are deserted, many of the closed business have de-fitted their premises and therefore won't be coming back. Let's hope the vaccination programme works, furlough is apparently extended until April '21 though which is worrying. Britain in 2021 feels, to me at least, like 1946. An unimaginable disaster has happened, if you're still here financially and mentally, things can surely to God only get Better!. Exactly after WW2 lets hope for a Strong Recovery!
Happy New Year and Good Luck to all in 2021!